Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Yim

Showing results (211-220 of 225) with videos related to

Pageof 23
Sort By:
Molecular Cancer Therapeutics|October 6, 2011
Identification of a natural compound by cell-based screening that enhances interferon regulatory factor-1 activity and causes tumor suppressionJinbo Gao, Yujun Wang, Quanhua Xing, et al.
Cancer Letters|December 29, 2014
Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cellsYujun Wang, Ernest Han, Quanhua Xing, et al.
NPJ Breast Cancer|June 27, 2017
Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12Brile Chung, Ali A Esmaeili, Sailesh Gopalakrishna-Pillai, et al.
Breast Cancer Research : BCR|November 10, 2019
Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancerJin Sun Lee, Susan E Yost, Suzette Blanchard, et al.
Molecular Cancer Therapeutics|October 17, 2014
Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancerWei Wen, Wei Liang, Jun Wu, et al.
Oncogene|April 1, 2014
SIRT2 regulates tumour hypoxia response by promoting HIF-1α hydroxylationK-S Seo, J-H Park, J-Y Heo, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 8, 2016
Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancersNoriko Kanaya, George Somlo, Jun Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Identification of Tissue-Specific DNA Methylation Signatures for Thyroid Nodule DiagnosticsJohn H Yim, Audrey H Choi, Arthur X Li, et al.
JCI Insight|February 8, 2022
Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor-positive breast cancerColt A Egelston, Weihua Guo, Jiayi Tan, et al.
The Oncologist|October 24, 2020
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Pageof 23

Showing results (211-220 of 225) with videos related to

Sort By:
Pageof 23
Molecular Cancer Therapeutics|October 6, 2011
Identification of a natural compound by cell-based screening that enhances interferon regulatory factor-1 activity and causes tumor suppressionJinbo Gao, Yujun Wang, Quanhua Xing, et al.
Cancer Letters|December 29, 2014
Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cellsYujun Wang, Ernest Han, Quanhua Xing, et al.
NPJ Breast Cancer|June 27, 2017
Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12Brile Chung, Ali A Esmaeili, Sailesh Gopalakrishna-Pillai, et al.
Breast Cancer Research : BCR|November 10, 2019
Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancerJin Sun Lee, Susan E Yost, Suzette Blanchard, et al.
Molecular Cancer Therapeutics|October 17, 2014
Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancerWei Wen, Wei Liang, Jun Wu, et al.
Oncogene|April 1, 2014
SIRT2 regulates tumour hypoxia response by promoting HIF-1α hydroxylationK-S Seo, J-H Park, J-Y Heo, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 8, 2016
Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancersNoriko Kanaya, George Somlo, Jun Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Identification of Tissue-Specific DNA Methylation Signatures for Thyroid Nodule DiagnosticsJohn H Yim, Audrey H Choi, Arthur X Li, et al.
JCI Insight|February 8, 2022
Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor-positive breast cancerColt A Egelston, Weihua Guo, Jiayi Tan, et al.
The Oncologist|October 24, 2020
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Pageof 23